| William Louis Porfilio, MD | |
|
1016 Kirkpatrick Road, Burlington, NC 27215-9714 | |
| (336) 228-0254 | |
| (336) 584-0101 |
| Full Name | William Louis Porfilio |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 1016 Kirkpatrick Road, Burlington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285836288 | NPI | - | NPPES |
| 5906899 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 200700790 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alamance Regional Medical Center | Burlington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alamance Eye Care Pa | 6103722699 | 10 |
News Archive
Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of high-grade serous ovarian cancer in mini-versions of the female reproductive organs of the mouse.
Nurses make up the largest and most trusted group of health care professionals, work on the front lines of the health care system, and are frequently called on to devise on-the-spot solutions to urgent health care problems, yet most nurses receive little or no training in how to effectively address these design challenges.
The American Society for Gastrointestinal Endoscopy (ASGE) lauds the recent news of the decline in U.S. colorectal cancer death and incidence rates. The report, released this week, shows that from 1975 to 2000, incidence rates dropped 22 percent and death rates dropped 26 percent.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
› Verified 4 days ago
| Entity Name | Alamance Eye Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184641524 PECOS PAC ID: 6103722699 Enrollment ID: O20031208000222 |
News Archive
Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of high-grade serous ovarian cancer in mini-versions of the female reproductive organs of the mouse.
Nurses make up the largest and most trusted group of health care professionals, work on the front lines of the health care system, and are frequently called on to devise on-the-spot solutions to urgent health care problems, yet most nurses receive little or no training in how to effectively address these design challenges.
The American Society for Gastrointestinal Endoscopy (ASGE) lauds the recent news of the decline in U.S. colorectal cancer death and incidence rates. The report, released this week, shows that from 1975 to 2000, incidence rates dropped 22 percent and death rates dropped 26 percent.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Louis Porfilio, MD 1016 Kirkpatrick Road, Burlington, NC 27215-9714 Ph: (336) 228-0254 | William Louis Porfilio, MD 1016 Kirkpatrick Road, Burlington, NC 27215-9714 Ph: (336) 228-0254 |
News Archive
Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of high-grade serous ovarian cancer in mini-versions of the female reproductive organs of the mouse.
Nurses make up the largest and most trusted group of health care professionals, work on the front lines of the health care system, and are frequently called on to devise on-the-spot solutions to urgent health care problems, yet most nurses receive little or no training in how to effectively address these design challenges.
The American Society for Gastrointestinal Endoscopy (ASGE) lauds the recent news of the decline in U.S. colorectal cancer death and incidence rates. The report, released this week, shows that from 1975 to 2000, incidence rates dropped 22 percent and death rates dropped 26 percent.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
› Verified 4 days ago
Chadwick R Brasington, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1016 Kirkpatrick Road, Burlington, NC 27215 Phone: 336-228-0254 Fax: 336-584-0101 | |
Dr. Bradley Mark King, MD, MPH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1016 Kirkpatrick Rd, Burlington, NC 27215 Phone: 336-228-0254 Fax: 336-584-0101 | |
Steven Andrew Dingeldein, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1016 Kirkpatrick Road, Burlington, NC 27215 Phone: 336-228-0254 Fax: 336-584-0101 | |
Dr. Nisha Mukherjee, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1016 Kirkpatrick Rd, Alamance Eye Center, Burlington, NC 27215 Phone: 336-228-0254 | |
Charles Ford Sydnor, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1016 Kirkpatrick Road, Burlington, NC 27215 Phone: 336-228-0254 Fax: 336-584-0101 | |
Blake Maxwell Hampton, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1016 Kirkpatrick Rd, Burlington, NC 27215 Phone: 336-228-0254 Fax: 336-584-0101 |